Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis

INTRODUCTION: Extraintestinal manifestations (EIMs) in patients with ulcerative colitis (UC) are common. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of UC. We evaluated the efficacy of tofacitinib in patients with EIMs, and the impact of tofacitinib on EIMs in pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Rubin, David T., Reinisch, Walter, Greuter, Thomas, Kotze, Paulo G., Pinheiro, Marcia, Mundayat, Rajiv, Maller, Eric, Fellmann, Marc, Lawendy, Nervin, Modesto, Irene, Vavricka, Stephan R., Lichtenstein, Gary R.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8132089/
https://ncbi.nlm.nih.gov/pubmed/34035832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562848211005708
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados